| # | Drug | Count |
|---|---|---|
| 0 | SOMATROPIN | 390 |
| 1 | PEGVISOMANT | 380 |
| 2 | OCTREOTIDE ACETATE | 293 |
| 3 | LEVOTHYROXINE SODIUM | 120 |
| 4 | LANREOTIDE ACETATE | 101 |
| 5 | METFORMIN | 95 |
| 6 | HYDROCORTISONE | 93 |
| 7 | CABERGOLINE | 86 |
| 8 | METFORMIN ER 500 MG | 84 |
| 9 | METFORMIN ER 750 MG | 84 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGVISOMANT | 380 | 0.0925 |
| 1 | PALTUSOTINE | 8 | 0.0336 |
| 2 | CABERGOLINE | 86 | 0.0175 |
| 3 | SOMAPACITAN-BECO | 3 | 0.0166 |
| 4 | LANREOTIDE ACETATE | 101 | 0.0127 |
| 5 | PASIREOTIDE | 26 | 0.0115 |
| 6 | OCTREOTIDE ACETATE | 293 | 0.0095 |
| 7 | MECASERMIN | 7 | 0.0086 |
| 8 | SOMATROPIN | 390 | 0.0052 |
| 9 | TESAMORELIN | 8 | 0.0047 |
| # | Drug class | Count |
|---|---|---|
| 0 | Recombinant Human Growth Hormone [EPC] | 138 |
| 1 | Corticosteroid [EPC] | 127 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 88 |
| 3 | Ergot Derivative [EPC] | 86 |
| 4 | Provitamin D2 Compound [EPC] | 64 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 56 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 48 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 44 |
| 8 | Benzodiazepine [EPC] | 43 |
| 9 | Androgen [EPC] | 42 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Ergot Derivative [EPC] | 86 | 0.0175 |
| 1 | Recombinant Human Growth Hormone [EPC] | 138 | 0.0063 |
| 2 | Somatostatin Analog [EPC] | 38 | 0.0055 |
| 3 | Carnitine Analog [EPC] | 9 | 0.0024 |
| 4 | Provitamin D2 Compound [EPC] | 64 | 0.0022 |
| 5 | Androgen [EPC] | 42 | 0.0015 |
| 6 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 3 | 0.0005 |
| 7 | Stimulant Laxative [EPC] | 5 | 0.0003 |
| 8 | Monoamine Oxidase Inhibitor [EPC] | 1 | 0.0003 |
| 9 | Aromatase Inhibitor [EPC] | 26 | 0.0002 |